Bottom line
FTDZX vs IBBQ: the short answer
FTDZX (Franklin Biotechnology Discovery Fund) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both mutual funds.
But IBBQ is far broader, holding 261 positions to 126 for FTDZX, so beyond the top names it adds exposure FTDZX doesn't have.
IBBQ is cheaper at 0.19% vs 0.76% — a difference of $57 a year per $10,000 invested.
Over one year, FTDZX returned +52.7% vs −0.6% for IBBQ (reporting dates differ).
Updated Nov 19, 2026
FTDZX vs IBBQ side by side
| FTDZX | IBBQ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.76% | 0.19% |
| Annual cost per $10k | $76 | $19 |
| 10-yr cost on $10k (prospectus) | $954 | $242 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +52.7% | −0.6% |
| 5-yr return (annualized) | +6.4% | — |
| 10-yr return (annualized) | +7.2% | — |
| Best quarter | — | +12.0% |
| Worst quarter | — | −11.7% |
| Net assets (fund) | $1.2B | $67.4M |
| Number of holdings | 126 | 261 |
| Portfolio turnover | 38% | 17% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of FTDZX's top 25 holdings also appear in IBBQ's top 25.
| Holding | FTDZX | IBBQ |
|---|---|---|
| Amgen, Inc. | 4.39% | 7.10% |
| Gilead Sciences, Inc. | 3.86% | 7.39% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 5.08% |
| Argenx SE | 3.62% | 1.89% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 7.38% |
| Revolution Medicines, Inc. | 3.01% | 2.48% |
| Guardant Health, Inc. | 2.76% | 1.35% |
| Insmed, Inc. | 1.99% | 1.83% |
| Neurocrine Biosciences, Inc. | 1.82% | 1.26% |
| Bridgebio Pharma, Inc. | 1.67% | 1.02% |
Source: SEC Form N-PORT
FTDZX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between FTDZX and IBBQ?
Which is cheaper, FTDZX or IBBQ?
Should I own both FTDZX and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.